Skip to main
TBI
TBI logo

TrueBlue (TBI) Stock Forecast & Price Target

TrueBlue (TBI) Analyst Ratings

Based on 1 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

TrueBlue Inc. has reported a year-over-year revenue increase of 2%, largely driven by significant growth within its commercial segment, which is indicative of robust demand for staffing services. Despite revenues falling slightly below guidance, the company's reported 20% year-over-year growth reflects strong performance and resilience in the business. Additionally, the 50 basis point improvement in adjusted EBITDA margin to 0.7% demonstrates effective cost management strategies, further supporting a positive outlook for the company's financial health.

Bears say

TrueBlue Inc's financial performance indicates significant challenges, as evidenced by a 320 basis point decline in adjusted EBITDA margin to 5.2% year-over-year, which fell well below forecasted expectations. The PeopleReady segment, which is the largest revenue generator, experienced a 5% year-over-year revenue decline, surpassing the expected midpoint guidance decline of 3%, highlighting ongoing weaknesses across various client verticals. Additionally, the company reported an adjusted loss per share of $(0.07) for 2Q25, further underscoring the financial strain faced by TrueBlue.

TrueBlue (TBI) has been analyzed by 1 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of TrueBlue and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About TrueBlue (TBI) Forecast

Analysts have given TrueBlue (TBI) a Buy based on their latest research and market trends.

According to 1 analysts, TrueBlue (TBI) has a Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $6, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $6, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

TrueBlue (TBI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.